Fildas aims for 109m-euro sales

Drug distributor Fildas estimates its sales will increase by 20% in 2005, thanks to the growth of the market and increased marketing operations. “Fildas is planning a 154 million-dollar (109 million-euro) turnover for 2005 and is aiming for 15% of the drug distribution market,” said Anca Vlad, general manager and company founder. Last year, the company made 91 million euros in turnover. In 2003, turnover was 52 million euros. Its shareholders are all Romanian individuals, with Anca Vlad the majority shareholder. Currently, most of Fildas’ sales come from pharmacies (80%), with the rest (20%) coming from hospitals, explained Vlad. Given that hospitals often delay paying suppliers, in some cases even for a number of years, most pharmaceutical distributors are cautious about dealing with them. Although the payment situation has improved somewhat of late, some hospitals are still to pay for deliveries made two years ago. ZF